Selling The Skinny
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
More On Patenting Privation: The Generics Strike Back
For those hoping for a quick answer to whether generics will be able to enter the market, it looks like it will take a Federal Circuit decision, probably by the end of 2026 at the earliest.
From ‘Associate’ To ‘Doppelganger’: The Evolution Of The Legal AI Persona
Confronting Biglaw’s ‘snake eating its own tail’ problem.